Arosii Due Diligence

Run due diligence on Arosii: check compliance and get alerts when suppliers or ownership change.

Denmark · owned by Independent (Denmark) · arosii.dk · 9 vendors

Arosii is a Danish IT solutions company focused on developing and scaling businesses through technology. Based in Denmark, the company offers IT services tailored to help organizations grow and optimize their operations. Their website is presented in Danish, indicating a primary focus on the Danish market.

Resilience scores

Technology vendors

Insights

Last updated 2026-09-13 · revision 4

9 direct vendors, 130 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Compliance

7 in-scope frameworks identified; showing 3.

ISO 27001 (source) — No public evidence

While not legally mandated, ISO 27001 is a key industry standard for information security management, particularly for a company handling sensitive health data and serving public sector clients.

SOC 2 (source) — No public evidence

SOC 2 is an assurance framework relevant for service organizations that handle customer data. While not a legal requirement, it is a common customer expectation in the technology sector.

MDR — No public evidence

Arosii develops bespoke IT solutions for the healthcare sector. It is plausible that some of this software could be classified as 'Software as a Medical Device' (SaMD) under the MDR, but this cannot be confirmed from public information.

Evidence: https://laegemiddelstyrelsen.dk/en/devices/legislation-and-guidance/guidance/~/media/D2C82054AC1748A58ED5D7487254AA71.ashx, https://radner.dk/regulatory-pathways-medical-devices-denmark-mdr-ivdr/, https://arosii.com/en/

Financials

Three-year financials

Financial Resilience Score: 7/10

Arosii A/S demonstrates solid financial resilience for a small, founder-owned Danish IT services firm. Gross profit has grown consistently every year from DKK 9.11M in FY 2021/22 to DKK 12.3M in FY 2024/25 (~35% cumulative on stable headcount), indicating rising productivity and pricing power. EBIT recovered from near break-even in FY 2022/23 (DKK 302K) to DKK 2.06M in FY 2024/25, and equity nearly quadrupled to DKK 26.8M, providing a substantial buffer relative to the ~15-18 person operation and the paid-in share capital of only DKK 500K. The company benefits from long-standing (~20 year) relationships in regulated healthcare-IT and clean-tech verticals, with sticky customers such as Sundhedsdatastyrelsen (Danish Health Data Authority), Nordex, Eniig and Suzlon. Founder ownership (Morten Kvistgaard Nielsen 48%, Claus Leth Gregersen) provides continuity, and the group structure with parent Arosii Information Systems Holding A/S and the Mobilize Me subsidiary offers additional cushioning. However, resilience is constrained by very small scale (~18 employees at a single Aarhus site), unquantified customer concentration among a handful of large accounts, and exposure to public-sector procurement and wind-industry capex cycles. The DKK 24.3M net profit spike in FY 2024/25 is non-recurring and appears driven by a non-operating financial gain (likely a subsidiary revaluation/divestment) rather than trading, so underlying operating profitability remains modest. Revenue is not disclosed under Danish small-company rules, limiting transparency.

Key strengths: Consistent gross profit growth (~35% cumulative over 4 years) on stable headcount, Strong equity buffer of DKK 26.8M vs. DKK 500K share capital, Long-standing (~20 year) customer relationships in regulated healthcare-IT and clean-tech verticals, Blue-chip customer base including Sundhedsdatastyrelsen, Nordex, Eniig, Suzlon, Founder-owned with continuity of management, Group backing from Arosii Information Systems Holding A/S and Mobilize Me subsidiary, EBIT recovery from DKK 302K to DKK 2.06M over three years

Risk factors: Very small scale (~15-18 employees) exposes company to key-person risk, Unquantified customer concentration among a few large accounts, Revenue not publicly disclosed, limiting transparency for lenders and counterparties, FY 2024/25 net profit spike (DKK 24.3M) is non-recurring and not operational, Exposure to public-sector procurement cycles via health-authority customers, Exposure to volatile wind-industry capex cycles (Nordex, Suzlon), Loss year experienced in 2021 (DKK -1.49M) shows historical vulnerability

Workforce by country

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report